Fractyl Health, Inc. Common Stock
GUTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22.5% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 46.2% | 35.8% | – | – |
| R&D Expenses | $70 | $38 | $34 | $26 |
| G&A Expenses | $0 | $0 | $15 | $10 |
| SG&A Expenses | $0 | $0 | $15 | $10 |
| Sales & Mktg Exp. | $0 | $0 | -$0 | $0 |
| Other Operating Expenses | $23 | $13 | $0 | $0 |
| Operating Expenses | $94 | $51 | $49 | $37 |
| Operating Income | -$94 | -$51 | -$49 | -$37 |
| % Margin | -100,571% | -42,363.3% | – | – |
| Other Income/Exp. Net | $25 | -$26 | $3 | -$2 |
| Pre-Tax Income | -$69 | -$77 | -$46 | -$39 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$69 | -$77 | -$46 | -$39 |
| % Margin | -73,864.5% | -64,242.5% | – | – |
| EPS | -1.62 | -1.98 | -1.34 | -1.12 |
| % Growth | 18.2% | -47.8% | -19.6% | – |
| EPS Diluted | -1.62 | -1.98 | -1.34 | -1.12 |
| Weighted Avg Shares Out | 44 | 48 | 48 | 48 |
| Weighted Avg Shares Out Dil | 44 | 48 | 48 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $1 | $0 | $0 | $1 |
| EBITDA | -$93 | -$51 | -$49 | -$36 |
| % Margin | -99,843% | -42,125% | – | – |